Speaker Profile

___	__
	Biography Dr. Bougie is currently an assistant professor at Queen’s University in the Department of Obstetrics and Gynecology. She attainted her medical degree at Queen’s University and completed her residency in Obstetrics and Gynecology at the University of Ottawa. She subsequently completing an AAGL Fellowship in Minimally Invasive Gynecology at the University of Ottawa, as well as a Masters of Public Health, Clinical Epidemiology at Harvard University. Her clinical interests include endoscopic surgery and complex benign gynecologic cases. Her research interests include endometriosis and patient-centered outcomes in gynecology. Disclosure 1. I have a relationship with a for-profit and/or a not-for-profit organization to disclose: a) Direct financial payments including receipt of honoraria: Abbvie (honoraria for CME), Pfizer (honoraria for CME) b) Membership on advisory boards or speakers’ bureaus: Pfizer, Abbvie 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).

Biography
Dr. Bougie is currently an assistant professor at Queen’s University in the Department of Obstetrics and Gynecology. She attainted her medical degree at Queen’s University and completed her residency in Obstetrics and Gynecology at the University of Ottawa. She subsequently completing an AAGL Fellowship in Minimally Invasive Gynecology at the University of Ottawa, as well as a Masters of Public Health, Clinical Epidemiology at Harvard University. Her clinical interests include endoscopic surgery and complex benign gynecologic cases. Her research interests include endometriosis and patient-centered outcomes in gynecology.
Disclosure
1. I have a relationship with a for-profit and/or a not-for-profit organization to disclose: a) Direct financial payments including receipt of honoraria: Abbvie (honoraria for CME), Pfizer (honoraria for CME) b) Membership on advisory boards or speakers’ bureaus: Pfizer, Abbvie 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).